An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

NCT02555709 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: VTP-43742
DRUG: Placebo 1
DRUG: Placebo 2

Sponsor

Vitae Pharmaceuticals Inc., an Allergan affiliate